Regarding: 'Epoetin beta treatment in patients with cancer chemotherapy induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events'.
Schwarzer
G
G
D000740:Anemia / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D018450:Disease Progression; D004921:Erythropoietin / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D011994:Recombinant Proteins; D013923:Thromboembolism / Q000209:etiology*
D000970:Antineoplastic Agents; D006454:Hemoglobins; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin